what if it is good be the biggest of all, the human genome product it were seeing patricia maisch medicine before our eyes from conventional therapy gene-based therapy, how to do that? we need a map. a map of the human genome. the nih did not end during the 1990s it developed a map of the genome. since then private companies have isolated specific genes and then i developed developing gene therapy, diagnostic techniques and otherwise of harnessing it. what has nih been? did develop a new center. and 2011 the national center for transitional sciences was launched to explicitly find private companies that would commercialize genomic therapy. what nih now does is to isolate genes, they find potential drugs from those genes. they actually do the preclinical study at labs and animals, they do some of the optional clinical studies in humans which private companies traditionally do and then they look for private partner which is when to take the drug once some of the risk has been taken out of once established it's a likely candidate. there will be huge profits huge therapeutic outcomes from then